HLA-A*02 genotype has been reported to be a strong prognostic factor linked to the aggressiveness of ovarian cancer of serous histology, prostate cancer and malignant melanoma [60] with a selective loss found in these and other types of cancer [47–49]. Here, HLA-A is linked to prostate carcinoma.